TY  - GEN
N2  - The purpose of this project is to calculate a therapeutic activity that assures the limit doses are not exceeded for critical organs in patients undergoing the I-131 MIBG / AZEDRA (Progenics Pharmaceuticals, Tarrytown, NY) therapy for pheochromocytoma and paraganglioma.
DO  - 10.6083/s1784m41b
DO  - DOI
AB  - The purpose of this project is to calculate a therapeutic activity that assures the limit doses are not exceeded for critical organs in patients undergoing the I-131 MIBG / AZEDRA (Progenics Pharmaceuticals, Tarrytown, NY) therapy for pheochromocytoma and paraganglioma.
AD  - Oregon Health and Science University
AD  - Oregon Health and Science University
T1  - Clinical dosimetry tool implementation of I-131 MIBG therapy for pheochromocytoma and paraganglioma
DA  - 2020
AU  - Franco, Roberto P.
AU  - Pugachev, Andrei
L1  - https://digitalcollections.ohsu.edu/record/8364/files/ResearchWeek.2020.Franco.Roberto.pdf
PB  - Oregon Health and Science University
LA  - eng
PY  - 2020
ID  - 8364
L4  - https://digitalcollections.ohsu.edu/record/8364/files/ResearchWeek.2020.Franco.Roberto.pdf
KW  - Pheochromocytoma
KW  - Paraganglioma
KW  - Radiation Monitoring
KW  - mibg
KW  - iodine-131
KW  - theragnostic
KW  - dosimetry
KW  - azedra
TI  - Clinical dosimetry tool implementation of I-131 MIBG therapy for pheochromocytoma and paraganglioma
Y1  - 2020
L2  - https://digitalcollections.ohsu.edu/record/8364/files/ResearchWeek.2020.Franco.Roberto.pdf
LK  - https://digitalcollections.ohsu.edu/record/8364/files/ResearchWeek.2020.Franco.Roberto.pdf
UR  - https://digitalcollections.ohsu.edu/record/8364/files/ResearchWeek.2020.Franco.Roberto.pdf
ER  -